Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    87,984.22
    +2,983.82 (+3.51%)
     

  • CMC Crypto 200

    1,371.97
    +59.34 (+4.52%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

TrendingWallStreet.com Begins Covering GILD, PFE, SKTO, and CSUN

ACCESSWIRE

Whether it’s a bull or bear market, TrendingWallStreet has you covered. Take a few minutes to register with us at http://www.trendingwallstreet.com/ to get exclusive access to our free stock reports.

Gilead Sciences Inc. (NASDAQ:GILD - News) shares closed up a modest 0.85 percent on Monday with about 5.8 million shares traded. The stock has a BUY rating with a price target of $107 at Bank of America Merrill Lynch. The rating is based on strong hepatitis C drug sales of Sovaldi, and the firm is under the assumption that the drug could have sales of $4.3 billion in 2014.

Get more information on Gilead Sciences Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/GILD

Pfizer Inc. (NYSE:PFE - News) shares closed up a modest 0.16 percent on Monday with about 14.8 million shares traded. It was announced recently that the company has come to terms with generic drugmaker Teva Pharmaceuticals (NYSE:TEVA - News) over its erectile dysfunction drug Viagra, with Teva due to launch its generic version two years early in 2017.

ADVERTISEMENT

Get more information on Pfizer Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/PFE

SK3 Group Inc. (OTC:SKTO - News) shares closed up 60.78 percent on Monday with nearly 46 million shares traded. The stock was one of the biggest gainers in the OTC market. There was no significant news to explain the breakout. On December 13th, the company had announced that their subsidiary Medical Greens announced that the first batch of Dharmanol™ has been manufactured and is ready to be rolled out for California distribution.

Get more information on SK3 Group Inc. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/SKTO

China Sunergy Co. Ltd. (NASDAQ:CSUN - News) shares closed up 22.96 percent on Monday with about 1 million shares traded. The stock was one of the biggest gainers on the NASDAQ. The company, a specialized solar cell and module manufacturer, announced that it has completed the sale of a solar farm project to Lightsource Renewable Energy Ltd., which is a UK's leading solar energy generator. The Project, located in the southwest of Cornwall in the United Kingdom (UK) was connected to the grid at the end of March of this year and now generates enough local green electricity to power over 1500 households.

Get more information on China Sunergy Co. Ltd. and free access to the in-depth equity report at: www.TrendingWallStreet.com/stockquote/CSUN

Disclosure: TrendingWallStreet.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.